PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Nuclear cardiology expands beyond perfusion imaging as it enters a new era
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
PET holds promise for carotid plaque assessments
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
Imaging offers insight into impact of new Alzheimer's treatment from Eli Lilly
Emerging research provides further evidence that amyloid-removal treatment for Alzheimer’s effectively slows cognitive decline.
Ozempic and similar weight loss drugs may impact medical imaging results
GLP-1 receptor agonists alter glucose metabolism and the movement of food through the digestive system and can lead to unique uptake patterns on FDG PET-CT.
An imaging AI 'epilepsy detective' could help cure treatment-resistant seizures
The tool can identify small focal cortical dysplasia on imaging that is typically missed by radiologists, bottom-of-sulcus dysplasia in particular.

molecular imaging study on brain connections in obese individuals

Obesity linked to altered brain connectivity on PET/MRI exams

New research, presented at SNMMI 2023, details how the brains of obese individuals differ from those who maintain a healthy weight.

SNMMI unveils Image of the Year

This year the Henry N. Wagner Jr., Image of the Year is actually a group of images displaying the efficacy of a 68Ga-DOTA-5G and 177Lu-DOTA-ABM-5G theranostic pairing that improves the detection and treatment of metastatic pancreatic cancer.

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

Folate-based radiopharmaceuticals could improve detection of gliomas

According to new research, gliomas—a deadly group of brain tumors that are difficult to treat—have increased folate receptor expression, meaning they also show increased uptake of folate-based radiopharmaceuticals on PET imaging.

Do clinicians want radiologists' management advice? Interviews shed some light on 'unwanted' recommendations

Clinicians only want the information they need to make treatment decisions, rather than advice on what actions they should take, the survey found.

Will PET imaging be covered alongside new Alzheimer's drugs? CMS dodges topic in new coverage decision

The recent CMS coverage determination did not make any mention of beta-amyloid PET imaging that is necessary for both diagnosing Alzheimer’s and monitoring the effectiveness of related treatments.

Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been dected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET a more cost-effective option for patients long-term compared to standard prostate imaging

The findings support adopting F-18 DCFPyL PET/CT as the standard of care for prostate cancer staging, authors of a new Scientific Reports paper concluded.

PET/CT

Nuclear cardiology expands beyond perfusion imaging as it enters a new era

PET holds promise for carotid plaque assessments

Imaging offers insight into impact of new Alzheimer's treatment from Eli Lilly

Ozempic and similar weight loss drugs may impact medical imaging results

An imaging AI 'epilepsy detective' could help cure treatment-resistant seizures